insights_auto
Why is AGIO down 2,75%?
Dive Deeperchevron_right
AGIO:NASDAQ
Agios Pharmaceuticals Inc
29,32 USD
arrow_downward
-2,75%(-0,83) 1D
17-ноя., 12:35:45 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AGIO...
Open
30,09 USD
High
30,38 USD
Low
28,94 USD
Mkt. cap
1,75 млд
Avg. vol.
1,23 млн
Volume
198,98 миң
52-wk high
45,99 USD
52-wk low
22,24 USD
EPS
-6,32 USD
Beta
0,66
Shares outstanding
59,81 млн
No. of employees
540
Open
30,09 USD
High
30,38 USD
Low
28,94 USD
Mkt. cap
1,75 млд
Avg. vol.
1,23 млн
Volume
198,98 миң
52-wk high
45,99 USD
52-wk low
22,24 USD
EPS
-6,32 USD
Beta
0,66
Shares outstanding
59,81 млн
No. of employees
540
News stories
From web sources and news partners
BigGo Finance
·
31 мүнөт мурун
Netflix Shares Trade Below S&P 500 Multiple After 35% Slide as Analysts See Upside
Benzinga
·
35 мүнөт мурун
S&P 500 Down 1%; Disney Posts Upbeat Earnings
Barron's
·
38 мүнөт мурун
Bear Market Watch: What the Charts Say About the S&P 500
Traders Union
·
31 мүнөт мурун
S&P 500 market cap falls $3 trillion over past week, Peter Tuchman notes
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
About Agios Pharmaceuticals Inc